P

    Plus Therapeutics Inc (PSTV)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $3.05
    -0.05 (-1.61%)

    Market Cap: $26.64M

    Last updated: Aug 28, 2026 at 5:00 PM ET

    Earnings

    Performance (10Y)

    Beat Rate
    64%(25/39)
    Avg Surprise
    +8.37%

    Upcoming Estimates

    Sep 30, 2026
    EPS Consensus$-0.86
    Range$-0.92 - $-0.80
    3 analysts
    EPS RevisionsNo revisions (7d)
    1
    2
    30d
    EPS Estimate Drift
    90d ago$-0.81+5.5%
    60d ago$0.00+100.0%
    30d ago$-0.85+1.2%
    7d ago$-0.86+0.0%
    Current$-0.86
    Revenue Consensus
    $1M
    Range$1M - $2M
    4 analysts
    Dec 31, 2026
    EPS Consensus$-1.31
    Range$-2.17 - $-0.78
    4 analysts
    Revenue Consensus
    $3M
    Range$450750 - $7M
    4 analysts
    PeriodReportedEst.SurpriseB/MYoY
    Dec 26EST
    		-$-1.31---
    Sep 26EST
    		-$-0.86---
    Jun 26
    		$N/A$-0.96N/ABeat-
    Mar 26
    		$-1.05$-0.87-20.69%Miss+92.6%
    Dec 25
    		$-0.04N/A+95.51%Beat+91.6%
    Sep 25
    		$-1.00$-0.87-14.94%Miss+89.2%
    Jun 25
    		$-0.16N/A+95.08%Beat+98.6%
    Mar 25
    		$-14.17$-7.33-93.32%Miss+24.4%
    Dec 24
    		$-0.49$-0.50+1.35%Beat+41.7%
    Sep 24
    		$-9.25$-14.06+34.21%Beat+63.0%
    Jun 24
    		$-11.25$-13.25+15.09%Beat+23.7%
    Mar 24
    		$-18.75$-27.25+31.19%Beat+64.3%
    Dec 23
    		$-0.84$-1.07+21.50%Beat-281.8%
    Sep 23
    		$-25.00$-29.42+15.02%Beat+64.9%
    Jun 23
    		$-14.75N/A+70.94%Beat+83.6%
    Mar 23
    		$-52.50$-55.00+4.55%Beat+26.3%
    Dec 22
    		$-0.22$-0.12-83.33%Miss+18.5%
    Sep 22
    		$-71.25$-80.00+10.94%Beat+32.0%
    Jun 22
    		$-90.00$-71.25-26.32%Miss+4.0%
    Mar 22
    		$-71.25$-71.25+0.00%Beat+42.4%
    Dec 21
    		$-0.27$-0.27+0.00%Beat+59.7%
    Sep 21
    		$-104.77$-91.25-14.82%Miss+28.4%
    Jun 21
    		$-93.75$-93.75+0.00%Beat-35957.7%
    Mar 21
    		$-123.75$-146.25+15.38%Beat+53.5%
    Dec 20
    		$-0.67$-0.39-71.79%Miss-391.3%
    Sep 20
    		$-146.25$-206.25+29.09%Beat-1200.0%
    Jun 20
    		$-0.26N/A+65.33%Beat+100.0%
    Mar 20
    		$-266.14$-281.25+5.37%Beat+92.1%
    Dec 19
    		$0.23N/A+134.85%Beat+102.9%
    Sep 19
    		$-11.25N/A+99.49%Beat+99.9%
    Jun 19
    		$-1920.00$-3750.00+48.80%Beat+82.6%
    Mar 19
    		$-3375.00$-3656.25+7.69%Beat+74.3%
    Dec 18
    		$-8.05$-14.67+45.13%Beat+83.9%
    Sep 18
    		$-10312.49$-4500.00-129.17%Miss+60.7%
    Jun 18
    		$-11062.49$-8925.00-23.95%Miss+68.9%
    Mar 18
    		$-13124.99$-10000.00-31.25%Miss+73.1%
    Dec 17
    		$-50.00$-42.50-17.65%Miss+58.3%
    Sep 17
    		$-26249.99$-29374.99+10.64%Beat+46.2%
    Jun 17
    		$-35624.98$-33749.98-5.56%Miss-
    Mar 17
    		$-48749.98$-57187.47+14.75%Beat-
    Dec 16
    		$-120.00$-115.00-4.35%Miss-
    Sep 16
    		$-48749.98$-44999.98-8.33%Miss-

    Key Metrics

    Valuation
    P/E Ratio-1.35EV/EBITDA29.14x
    Price/FCF-0.89xFCF Yield-111.92%
    Profitability
    Profit Margin-230.20%Operating Margin-693.00%
    ROE-522.00%ROICN/A
    Financial Health
    Debt/EquityN/AInterest CoverageN/A
    Current Ratio1.37xQuick Ratio1.37x
    Trading Statistics
    Beta1.42Avg Volume78.72K
    52-Week High$23.4352-Week Low$2.90

    Technical Indicators Dashboard

    Moving Averages

    SMA 10$3.08
    SMA 20$3.43
    SMA 50$3.76
    SMA 200$7.32
    EMA 10$3.16
    EMA 20$3.35
    EMA 50$3.87
    EMA 200$6.86

    MACD

    Line: -0.26Signal: -0.24Hist: -0.01

    ADX

    ADX: 23.1+DI: 15.0-DI: 22.7

    Aroon & PSAR

    Aroon Up28.0
    Aroon Down84.0
    PSAR$3.78

    Bollinger Bands

    Upper Band$4.18
    Lower Band$2.67
    %B Position4405%(Upper)
    Band Width0.25

    RSI (14-Day)

    Neutral
    36.0

    Momentum Oscillators

    Stoch %K12.6
    Stoch %D11.7
    Williams %R-87.5
    ROC (10d)-17.1%
    Momentum-0.63
    CCI (20d)-67.9
    MFI (14d)20.2

    Volatility Measures

    ATR (14d)$0.25(8.3%)
    StdDev (20d)0.38
    Hist Vol82.6%(High)

    Volume Flow

    VWAP$3.08
    OBV2.4B
    AD Line1278.4B
    CMF (20d)-0.155

    Volume Metrics

    Avg Vol (20d)79.2K
    Vol Ratio0.4x(Low)
    VWMA (20d)$3.45

    Pivot Points

    R3$3.50
    R2$3.37
    R1$3.24
    Pivot Point$3.11
    S1$2.98
    S2$2.85
    S3$2.72

    Advanced Oscillators

    TSI-29.31
    Ultimate Osc38.2
    KST-186.56

    Financial Data

    QuarterJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023Sep 2023
    Total Revenue$411,000$1.03M$1.37M$1.40M$1.39M$1.06M$1.41M$1.46M$1.28M$1.68M$1.31M$1.24M
    Cost of Revenue$0$0$92,000$0$0$0$232,000$0$0$0$182,000$0
    Gross Profit$411,000$1.03M$1.37M$1.40M$1.39M$1.06M$1.41M$1.46M$1.28M$1.68M$1.31M$1.24M
    Operating Expenses$9.47M$8.15M$7.11M$5.88M$2.93M$4.59M$5.31M$5.25M$4.98M$4.98M$5.17M$4.49M
    R&D$4.26M$2.87M$2.94M$2.44M$1.25M$1.76M$2.19M$2.86M$2.77M$2.76M$2.79M$2.49M
    SG&A$5.20M$5.28M$4.17M$3.44M$1.68M$2.84M$3.13M$2.40M$2.20M$2.21M$2.38M$2.00M
    Operating Income$-9,057,000$-7,119,000$-5,742,000$-4,482,000$-1,538,000$-3,536,000$-3,900,000$-3,799,000$-3,697,000$-3,299,000$-3,858,000$-3,251,000
    Interest Income$56,000$190,000$29,000$59,000$27,000$1,000$54,000$80,000$67,000$72,000$110,000$119,000
    Interest Expense$5,000$17,000$0$0$0$548,000$57,000$61,000$27,000$34,000$62,000$87,000
    Income Before Tax$-9,006,000$-6,946,000$-5,713,000$-4,423,000$5.15M$-17,401,000$-3,903,000$-2,874,000$-2,940,000$-3,261,000$-3,810,000$-3,219,000
    Income Tax Expense$0$0$0$0$0$0$0$0$0$0$0$0
    Net Income$-9,006,000$-6,946,000$-5,713,000$-4,423,000$5.15M$-17,401,000$-3,903,000$-2,874,000$-2,940,000$-3,261,000$-3,810,000$-3,219,000
    EBITDA$-8,900,000$-7,031,000$-5,587,000$-4,402,000$5.14M$-16,673,000$-3,613,000$-2,741,000$-2,830,000$-3,127,000$-3,763,000$-3,022,000
    EBIT$-9,057,000$-7,119,000$-5,742,000$-4,482,000$5.12M$-16,854,000$-3,900,000$-2,893,000$-2,980,000$-3,299,000$-3,858,000$-3,251,000
    * Some calculated fields are derived from available data when not provided by source

    Related GNG Research

    No research available

    Be the first to write about PSTV

    News

    CNSY - PSTV: 15 Million Financing And Prefunded Warrants Will Drive Clinical Progress

    Plus Therapeutics (PSTV) has secured $15 million in financing and prefunded warrants, which analysts believe will accelerate clinical progress. While some analysts are bullish on the long-term potential, reflecting an updated fair value of $38, others express caution due to execution risks and valuation concerns, lowering their price targets. The company's strategic advancements in manufacturing, new CPT codes, and clinical trial progress, along with strengthened leadership, are seen as key drivers for future growth and potential market opportunities.

    Simply Wall Street•8/6/26•
    Somewhat-Bullish

    Plus Therapeutics amends bylaws to reflect corporate name change to Cerenome

    Plus Therapeutics has amended its bylaws to reflect a corporate name change to Cerenome, effective August 3, 2026. The company's Nasdaq trading symbol also switched to CNSY on the same date, though the CUSIP for the common stock remains unchanged. This news brief was generated by AI, based on original content filed by Plus Therapeutics Inc. with the SEC.

    Bitget•8/5/26•
    Neutral

    Plus Therapeutics presents REYOBIQ data at neurosurgery meeting

    Plus Therapeutics (PSTV) presented encouraging clinical data for its radiopharmaceutical REYOBIQ at the 2026 American Association of Neurological Surgeons Annual Scientific Meeting. The data from the Phase 1 ReSPECT-LM trial, which evaluates REYOBIQ for leptomeningeal metastases, showed a median overall survival of approximately 9 months and robust anti-tumor activity. The treatment also demonstrated immune remodeling within the tumor microenvironment and a high target-to-off-target absorbed dose ratio.

    Investing.com•8/5/26•
    Bullish

    Discontinued operations of PLUS THERAPEUTICS, Inc. – NASDAQ:CNSY

    This article briefly reports on the discontinued operations of PLUS THERAPEUTICS, Inc. (NASDAQ: CNSY). The content is minimal, essentially just stating the fact and indicating that the market for CNSY is closed with no trades. It provides no further details regarding the reasons or implications of the discontinued operations.

    TradingView•8/4/26•
    Bearish

    Cash flow from financing activities of PLUS THERAPEUTICS, Inc. – BOATS:CNSY

    This article focuses on the cash flow from financing activities for PLUS THERAPEUTICS, Inc. (CNSY) as displayed on TradingView. It provides a financial overview of the company, indicating that the market is currently closed with no trades. The content primarily highlights financial data and various tools available on the TradingView platform.

    TradingView•8/3/26•
    Neutral

    Frequently Asked Questions About PSTV

    Does PSTV pay dividends?
    Plus Therapeutics Inc (PSTV) does not currently pay a regular dividend.
    What is PSTV's market cap?
    Plus Therapeutics Inc (PSTV) has a market capitalization of $26.64M with a current stock price of $3.05.

    Get full access to GNG Research

    Create a free account to access portfolio tracking, advanced tools, and more.

    Create Free AccountLog In